The Antibody-based Proteomics Core provides cutting edge antibody-based proteomic platforms for both validation and protein biomarker discovery, particularly for low abundance regulatory proteins and ...

Removing fucose, and creating a “nonfucosylated” antibody, improved effector function, resulting in a more potent immune response. The therapy in this study targets CD70, which is expressed on ...